 Jacob Lebin
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Narcotic Antagonists | 5 | 2025 | 204 | 2.680 |
Why?
| | Alcoholism | 5 | 2026 | 821 | 2.180 |
Why?
| | Naloxone | 4 | 2025 | 132 | 2.050 |
Why?
| | Emergency Service, Hospital | 7 | 2026 | 2379 | 1.630 |
Why?
| | Drug Prescriptions | 3 | 2025 | 287 | 1.510 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2025 | 188 | 1.450 |
Why?
| | Drug Overdose | 6 | 2021 | 374 | 1.330 |
Why?
| | Decision Support Systems, Clinical | 2 | 2025 | 271 | 1.320 |
Why?
| | Analgesics, Non-Narcotic | 2 | 2021 | 127 | 1.250 |
Why?
| | Hydroxychloroquine | 2 | 2021 | 65 | 1.230 |
Why?
| | Analgesics, Opioid | 4 | 2025 | 1150 | 1.170 |
Why?
| | Naltrexone | 2 | 2025 | 118 | 0.880 |
Why?
| | Crataegus | 2 | 2020 | 8 | 0.810 |
Why?
| | Chloroquine | 2 | 2021 | 54 | 0.790 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2021 | 138 | 0.770 |
Why?
| | Syncope | 1 | 2023 | 56 | 0.770 |
Why?
| | Acetaminophen | 3 | 2021 | 266 | 0.750 |
Why?
| | Delirium | 1 | 2024 | 105 | 0.730 |
Why?
| | Opiate Substitution Treatment | 1 | 2025 | 186 | 0.720 |
Why?
| | Methylene Blue | 2 | 2021 | 24 | 0.720 |
Why?
| | Circulating MicroRNA | 1 | 2021 | 26 | 0.680 |
Why?
| | Buprenorphine | 1 | 2025 | 190 | 0.670 |
Why?
| | Hand Sanitizers | 1 | 2020 | 2 | 0.650 |
Why?
| | Opioid-Related Disorders | 3 | 2025 | 601 | 0.640 |
Why?
| | Sodium Chloride | 1 | 2020 | 143 | 0.600 |
Why?
| | Practice Patterns, Physicians' | 2 | 2025 | 1369 | 0.600 |
Why?
| | Dietary Supplements | 2 | 2020 | 580 | 0.590 |
Why?
| | Seizures | 1 | 2023 | 482 | 0.580 |
Why?
| | Anesthetics, Dissociative | 1 | 2019 | 46 | 0.570 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 70 | 0.560 |
Why?
| | Oxymorphone | 1 | 2018 | 5 | 0.560 |
Why?
| | Prescription Drug Diversion | 1 | 2018 | 13 | 0.550 |
Why?
| | Narcotics | 1 | 2018 | 58 | 0.540 |
Why?
| | Oxycodone | 1 | 2018 | 54 | 0.530 |
Why?
| | Ketamine | 1 | 2019 | 137 | 0.520 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.510 |
Why?
| | Teratoma | 1 | 2018 | 124 | 0.500 |
Why?
| | Nitric Oxide | 1 | 2021 | 894 | 0.470 |
Why?
| | Benzodiazepines | 3 | 2023 | 168 | 0.470 |
Why?
| | MicroRNAs | 1 | 2021 | 689 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 389 | 0.440 |
Why?
| | Pandemics | 2 | 2020 | 1706 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 383 | 0.430 |
Why?
| | Humans | 32 | 2026 | 145482 | 0.420 |
Why?
| | Alcohol Drinking | 1 | 2020 | 837 | 0.390 |
Why?
| | Hospitalization | 2 | 2025 | 2458 | 0.390 |
Why?
| | Phenobarbital | 2 | 2023 | 21 | 0.380 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 595 | 0.350 |
Why?
| | Emergency Medical Services | 1 | 2019 | 697 | 0.350 |
Why?
| | Acetylcysteine | 2 | 2021 | 137 | 0.330 |
Why?
| | Sodium Nitrite | 2 | 2021 | 39 | 0.320 |
Why?
| | Retrospective Studies | 8 | 2026 | 17262 | 0.310 |
Why?
| | Adult | 12 | 2025 | 40703 | 0.290 |
Why?
| | Female | 14 | 2026 | 78756 | 0.280 |
Why?
| | Male | 13 | 2026 | 72808 | 0.250 |
Why?
| | Electronic Health Records | 2 | 2025 | 1186 | 0.250 |
Why?
| | Alcohol Deterrents | 1 | 2025 | 26 | 0.220 |
Why?
| | Middle Aged | 6 | 2026 | 36169 | 0.210 |
Why?
| | Rivastigmine | 1 | 2024 | 6 | 0.210 |
Why?
| | Lorazepam | 1 | 2023 | 25 | 0.200 |
Why?
| | Inpatients | 2 | 2025 | 550 | 0.200 |
Why?
| | Eating | 2 | 2021 | 388 | 0.180 |
Why?
| | Poisons | 1 | 2021 | 20 | 0.170 |
Why?
| | Methemoglobinemia | 1 | 2020 | 13 | 0.160 |
Why?
| | Antidotes | 1 | 2021 | 145 | 0.150 |
Why?
| | Gold Compounds | 1 | 2019 | 4 | 0.150 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.150 |
Why?
| | Fatal Outcome | 1 | 2020 | 306 | 0.150 |
Why?
| | Digoxin | 1 | 2019 | 27 | 0.150 |
Why?
| | Cardiotoxicity | 1 | 2019 | 35 | 0.150 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2019 | 57 | 0.150 |
Why?
| | Potassium Cyanide | 1 | 2019 | 24 | 0.150 |
Why?
| | Acidosis, Lactic | 1 | 2019 | 46 | 0.150 |
Why?
| | Administration, Intranasal | 1 | 2019 | 94 | 0.140 |
Why?
| | Insurance Coverage | 1 | 2020 | 243 | 0.140 |
Why?
| | Gold | 1 | 2019 | 116 | 0.140 |
Why?
| | Administration, Intravenous | 1 | 2019 | 171 | 0.140 |
Why?
| | Respiratory Aspiration | 1 | 2018 | 32 | 0.140 |
Why?
| | Referral and Consultation | 1 | 2024 | 862 | 0.130 |
Why?
| | Prescription Drug Misuse | 1 | 2018 | 52 | 0.130 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 326 | 0.130 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2772 | 0.130 |
Why?
| | Vasodilation | 1 | 2021 | 521 | 0.130 |
Why?
| | Plant Extracts | 1 | 2019 | 188 | 0.130 |
Why?
| | Vomiting | 1 | 2018 | 132 | 0.130 |
Why?
| | Commerce | 1 | 2018 | 80 | 0.130 |
Why?
| | Mass Screening | 1 | 2026 | 1358 | 0.130 |
Why?
| | Methadone | 1 | 2019 | 122 | 0.130 |
Why?
| | Abdominal Pain | 1 | 2018 | 149 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 261 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2021 | 712 | 0.110 |
Why?
| | Comorbidity | 1 | 2020 | 1659 | 0.110 |
Why?
| | Home Care Services | 1 | 2019 | 282 | 0.110 |
Why?
| | Chronic Disease | 1 | 2020 | 1816 | 0.110 |
Why?
| | Sex Factors | 1 | 2020 | 2110 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2019 | 11826 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2020 | 8320 | 0.100 |
Why?
| | Age Factors | 1 | 2020 | 3339 | 0.090 |
Why?
| | Aged | 4 | 2026 | 26117 | 0.090 |
Why?
| | Clinical Laboratory Techniques | 1 | 2013 | 97 | 0.090 |
Why?
| | Suicide | 1 | 2019 | 728 | 0.090 |
Why?
| | Phenylbutyrates | 1 | 2011 | 23 | 0.080 |
Why?
| | Oncogene Proteins | 1 | 2011 | 61 | 0.080 |
Why?
| | Elbow | 1 | 2011 | 56 | 0.080 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 130 | 0.080 |
Why?
| | Elbow Joint | 1 | 2011 | 73 | 0.080 |
Why?
| | Young Adult | 4 | 2024 | 14192 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5891 | 0.060 |
Why?
| | Prospective Studies | 1 | 2018 | 8039 | 0.060 |
Why?
| | Obstetrics and Gynecology Department, Hospital | 1 | 2024 | 7 | 0.050 |
Why?
| | Infant | 1 | 2019 | 10064 | 0.050 |
Why?
| | Parkinson Disease | 1 | 2011 | 601 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 195 | 0.050 |
Why?
| | Primary Health Care | 1 | 2013 | 1734 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 151 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2024 | 370 | 0.040 |
Why?
| | Methemoglobin | 1 | 2020 | 24 | 0.040 |
Why?
| | Poison Control Centers | 1 | 2021 | 84 | 0.040 |
Why?
| | United States | 1 | 2018 | 16114 | 0.040 |
Why?
| | Plant Roots | 1 | 2019 | 45 | 0.040 |
Why?
| | Iron | 1 | 2021 | 359 | 0.040 |
Why?
| | Exercise | 1 | 2011 | 2192 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 696 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2024 | 612 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 379 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1157 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1500 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2915 | 0.030 |
Why?
| | Weight Loss | 1 | 2019 | 839 | 0.020 |
Why?
| | Liver | 1 | 2021 | 1895 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 22485 | 0.020 |
Why?
| | Delayed Diagnosis | 1 | 2013 | 100 | 0.020 |
Why?
| | Medical Errors | 1 | 2013 | 119 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 7197 | 0.020 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2011 | 13 | 0.020 |
Why?
| | Peroxiredoxins | 1 | 2011 | 26 | 0.020 |
Why?
| | Torque | 1 | 2011 | 82 | 0.020 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 230 | 0.020 |
Why?
| | Muscular Diseases | 1 | 2011 | 108 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2013 | 336 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2011 | 98 | 0.020 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 147 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2011 | 218 | 0.020 |
Why?
| | Patient Participation | 1 | 2013 | 437 | 0.020 |
Why?
| | Isometric Contraction | 1 | 2011 | 190 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 428 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 848 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2011 | 430 | 0.020 |
Why?
| | Proteins | 1 | 2011 | 1020 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2011 | 1350 | 0.010 |
Why?
| | Quality Improvement | 1 | 2013 | 1294 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4127 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11837 | 0.010 |
Why?
| | Neurons | 1 | 2011 | 1647 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 4283 | 0.010 |
Why?
| | Child | 1 | 2018 | 22680 | 0.010 |
Why?
| | Mice | 1 | 2011 | 18338 | 0.010 |
Why?
| | Animals | 1 | 2011 | 38141 | 0.000 |
Why?
|
|
Lebin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|